arrow
Back
G

G Rogers

manchester centre for health economics

20H-index
95Paper Count
2.2KCitation Count
Published Papers 22
Publication Date
Cost-Utility Analyses of Systemic Treatments for Psoriasis and Psoriatic Arthritis in the UK: A Systematic Review of Modelling Methods
err2026-07-08
err0
PREAI
errThomas S. Clemmet; Duc Binh Phan; Alice Copson; Richard B. Warren; Zenas Z. N. Yiu; Gabriel Rogers
errShare
errSave
Using biologic therapies as first-line systemic treatment for psoriasis: A cohort study following the target trial emulation framework from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
err2026-03-16
err0
errOAAI
errDuc Binh Phan; Philip Laws; Catherine H Smith; Christopher E M Griffiths; Brian Kirby; Olivia Hughes; Gabriel Rogers; Oras A Alabas; Mark Lunt; Richard B Warren; Zenas Z N Yiu
errShare
errSave
Estimating the economic effect of harm associated with high risk prescribing of oral non-steroidal anti-inflammatory drugs in England: population based cohort and economic modelling study
err2024-07-24
err0
errOAAI
errCamacho, Elizabeth M.; Penner, Leonie S.; Taylor, Amy; Guthrie, Bruce; Avery, Anthony J.; Ashcroft, Darren M.; Morales, Daniel R.; Rogers, Gabriel; Chuter, Antony; Elliott, Rachel A.
errShare
errSave
Estimating the cost-effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in England
err2023-10-06
err4
errOAAI
errElliott, Rachel A.; Rogers, Gabriel; Evans, Mark L.; Neupane, Sankalpa; Rayman, Gerry; Lumley, Sarah; Cranston, Iain; Narendran, Parth; Sutton, Christopher J.; Taxiarchi, Vicky P.; Burns, Matthew; Thabit, Hood; Wilmot, Emma G.; Leelarathna, Lalantha
errShare
errSave
Development and validation of paired MEDLINE and Embase search filters for cost-utility studies
err2022-12-03
err4
errOAAI
errHubbard, Wesley; Walsh, Nicola; Hudson, Thomas; Heath, Andrea; Dietz, Jeremy; Rogers, Gabriel
errShare
errSave
GUIDELINES Parkinson's disease: summary of updated NICE guidance
err2017-07-27
err70
PREAI
errRogers, Gabriel; Davies, Debbie; Pink, Joshua; Cooper, Paul
errShare
errSave
GUIDELINES Spondyloarthritis: diagnosis and management: summary of NICE guidance
err2017-03-01
err12
PREAI
errMcAllister, Katherine; Goodson, Nicola; Warburton, Louise; Rogers, Gabriel
errShare
errSave
errShare
errSave
Temozolomide for high grade glioma
err2013-04-30
err127
errOAAI
errHart, Michael G.; Garside, Ruth; Rogers, Gabriel; Stein, Ken; Grant, Robin
errShare
errSave
Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model
err2012-11-22
err86
errOAAI
errHyde, Christopher; Peters, Jaime; Bond, Mary; Rogers, Gabriel; Hoyle, Martin; Anderson, Rob; Jeffreys, Mike; Davis, Sarah; Thokala, Praveen; Moxham, Tiffany
errShare
errSave
errShare
errSave
errShare
errSave
errShare
errSave
Chemotherapy wafers for high grade glioma
err2011-03-16
err52
errOAAI
errHart, M. G.; Grant, R.; Garside, R.; Rogers, G.; Somerville, M.; Stein, K.
errShare
errSave
Reply: SUN vs BEVpIFN in first-line mRCC therapy: no evidence for a statistically significant difference in progression-free survival
err2010-01-05
err0
errOAAI
errCoon, J. S. Thompson; Liu, Z.; Hoyle, M.; Rogers, G.; Green, C.; Moxham, T.; Welch, K.; Stein, K.
errShare
errSave
errShare
errSave
The harmful health effects of recreational ecstasy: a systematic review of observational evidence
err2009-02-01
err103
errOAAI
errRogers, G.; Elston, J.; Garside, R.; Roome, C.; Taylor, R.; Younger, P.; Zawada, A.; Somerville, M.
errShare
errSave
Temozolomide for High Grade Glioma
err2008-10-08
err59
errOAAI
errHart, Michael G.; Grant, Robert; Garside, Ruth; Rogers, Gabriel; Somerville, Margaret; Stein, Ken
errShare
errSave